Brief: Gritstone bio Q3 basic EPS USD -0.33
08/11/2023 22:58
Nov 8 (Reuters) - Gritstone bio Q3 net income USD -38.434 million. * Q3 basic EPS USD -0.33 * Q3 operating expenses USD 40.169 million * Q3 collaboration & license revenue USD 361 thousand * Q3 operating income USD -38.604 million
Recent news on Gritstone bio
See all newsBrief: Gritstone Bio Inc On Dec 31 2024, Vassiliki “Celia” Economides Became Interim CEO As Well As CFO Of Co
Brief: Gritstone Bio Announces Strengthening Of Maturing Phase 2 PFS Data for GRANITE Study And Provides Business Update
U.S. STOCKS ON THE MOVE-Avery Dennison, Snap-On, Avadel Pharma
U.S. STOCKS ON THE MOVE-Avery Dennison, Snap-On, Avadel Pharma
U.S. STOCKS ON THE MOVE-PPG Industries, Travelers, ShiftPixy